Almirall SA
OTC:LBTSF

Watchlist Manager
Almirall SA Logo
Almirall SA
OTC:LBTSF
Watchlist
Price: 15.47 USD Market Closed
Market Cap: 3.3B USD

Relative Value

The Relative Value of one LBTSF stock under the Base Case scenario is hidden USD. Compared to the current market price of 15.47 USD, Almirall SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LBTSF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
36
vs Industry
59
Median 3Y
1.5
Median 5Y
1.6
Industry
2.7
Forward
2.5
vs History
31
vs Industry
0
Median 3Y
-45.9
Median 5Y
25.4
Industry
21.6
Forward
37.1
vs History
36
vs Industry
29
Median 3Y
13.6
Median 5Y
13.2
Industry
16.9
vs History
0
vs Industry
10
Median 3Y
-16.7
Median 5Y
-5.3
Industry
22.9
vs History
3
vs Industry
49
Median 3Y
1.3
Median 5Y
1.4
Industry
2.3
vs History
39
vs Industry
59
Median 3Y
1.5
Median 5Y
1.6
Industry
3
Forward
2.5
vs History
38
vs Industry
69
Median 3Y
2
Median 5Y
2.2
Industry
5.6
vs History
12
vs Industry
30
Median 3Y
10.2
Median 5Y
9.6
Industry
13.4
Forward
11.9
vs History
39
vs Industry
12
Median 3Y
31.5
Median 5Y
23.4
Industry
16.7
Forward
31.6
vs History
38
vs Industry
29
Median 3Y
13.4
Median 5Y
13.3
Industry
16.1
vs History
9
vs Industry
8
Median 3Y
45.4
Median 5Y
24.4
Industry
18.9
vs History
3
vs Industry
53
Median 3Y
1
Median 5Y
1.1
Industry
2

Multiples Across Competitors

LBTSF Competitors Multiples
Almirall SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Almirall SA
OTC:LBTSF
2.8B USD 1.8 51 10.6 24.6
US
Eli Lilly and Co
NYSE:LLY
977B USD 16.4 53.1 35.6 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
528.3B USD 5.7 21 17.2 22.3
CH
Roche Holding AG
SIX:ROG
275.3B CHF 4.5 29.2 12.4 14.5
UK
AstraZeneca PLC
LSE:AZN
217.5B GBP 5 31 108.3 158.5
CH
Novartis AG
SIX:NOVN
219.7B CHF 4.9 19 12 15.5
US
Merck & Co Inc
NYSE:MRK
276B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
147.2B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
ES
Almirall SA
OTC:LBTSF
Average P/E: 27.7
51
150%
0.3
US
Eli Lilly and Co
NYSE:LLY
53.1
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
21
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.2
29%
1
UK
AstraZeneca PLC
LSE:AZN
31
37%
0.8
CH
Novartis AG
SIX:NOVN
19
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ES
Almirall SA
OTC:LBTSF
Average EV/EBITDA: 400.9
10.6
20%
0.5
US
Eli Lilly and Co
NYSE:LLY
35.6
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.2
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.4
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
12
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ES
Almirall SA
OTC:LBTSF
Average EV/EBIT: 1 714.6
24.6
56%
0.4
US
Eli Lilly and Co
NYSE:LLY
38.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.3
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
7%
1.5